Clonidine and Hepatic cyst - a phase IV clinical study of FDA data

Summary:

Hepatic cyst is reported as a side effect among people who take Clonidine (clonidine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Aredia, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hepatic cyst when taking Clonidine. It is created by eHealthMe based on reports of 63,883 people who have side effects when taking Clonidine from the FDA, and is updated regularly.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

What is Hepatic cyst?

Hepatic cyst is found to be associated with 779 drugs and 649 conditions by eHealthMe. Check the latest studies of Hepatic cyst.

On Jul, 29, 2026

63,883 people reported to have side effects when taking Clonidine.
Among them, 32 people (0.05%) have Hepatic cyst.

Among these 32 people:

How long have people been on Clonidine when they have Hepatic cyst? *

What is the gender of people who have Hepatic cyst when taking Clonidine? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Hepatic cyst when taking Clonidine? *

What are other drugs people take besides Clonidine? *

What are other side effects people have besides Hepatic cyst? *

Stress And Anxiety: 18 people, 56.25%
Renal Cyst (kidney cyst): 17 people, 53.12%
Back Pain: 16 people, 50.00%
Depression: 16 people, 50.00%
Pain: 16 people, 50.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 43.75%
Atelectasis (partial or complete collapse of the lung): 14 people, 43.75%
Osteonecrosis Of Jaw (death of bone of jaw): 13 people, 40.62%
Anaemia (lack of blood): 13 people, 40.62%
Enlarged Heart: 13 people, 40.62%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 21.88%
White Blood Cell Disorder: 4 people, 12.50%
Renal Disorder (kidney disease): 4 people, 12.50%
Electrolyte Imbalance: 4 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 12.50%
Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls): 4 people, 12.50%
Leukocytosis (increased white blood cells): 4 people, 12.50%
Prostate Cancer Metastatic: 4 people, 12.50%
Infection: 4 people, 12.50%
Sedation: 4 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and have Hepatic cyst?

- Check whether Hepatic cyst is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clonidine:

Clonidine (65,644 reports)

Hepatic cyst treatments and more:

Hepatic cyst (5,071 reports)

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic cyst:

Hepatic cyst (779 drugs)

Browse all the conditions that are associated with Hepatic cyst:

Hepatic cyst (649 conditions)

Related publications that referenced our studies

Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.